1-8 of 8
Eirini Katodrytou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Iberdomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: An update from the phase 2 EMN26 trial

Free
Niels W.C.J. van de Donk, Cyrille Touzeau, Evangelos Terpos, Aurore Perrot, Roberto Mina, Maaike de Ruijter, Elisabetta Antonioli, Eirini Katodrytou, Norbert Pescosta, Paulus A.F. Geerts, Cecile Sonntag Mottier, Ruth Wester, Angelo Belotti, Silvia Mangiacavalli, Massimo Offidani, Mattia D'Agostino, Mark van Duin, Paola Tacchetti, Sara Aquino, Alessandra Lombardo, Mark-David Levin, Cyrille Hulin, Mario Boccadoro, Pieter Sonneveld, Francesca Gay
Journal: Blood
Blood (2025) 146 (Supplement 1): 101.
https://doi.org/10.1182/blood-2025-101
Published: 2025
Journal Articles

Response-adapted randomization to Q2W vs Q4W isatuximab beyond cycle 6 in relapsed multiple myeloma: Results from a phase 2 Study of isa-pd in lenalidomide- and PI-exposed patients

Free
Evangelos Terpos, Maria Gavriatopoulou, Vasiliki Lampropoulou, Emmanouil Spanoudakis, Eirini Katodrytou, Anastasia Sioni, Eleftheria Hatzimichael, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Eirini Solia, Nikolaos Kanellias, Helen Vassalou, Nikolaos Giannakoulas, Sosana Delimpasi, Maria Kotsopoulou, Efstathios Kastritis, Meletios Dimopoulos
Journal: Blood
Blood (2025) 146 (Supplement 1): 4037.
https://doi.org/10.1182/blood-2025-4037
Published: 2025
Journal Articles

Isatuximab with bortezomib, cyclophosphamide, and dexamethasone followed by isatuximab and lenalidomide maintenance in newly diagnosed multiple myeloma patients with severe renal impairment: Final analysis of a phase 2 study by the greek myeloma study group

Free
Evangelos Terpos, Efstathios Kastritis, Sosana Delimpasi, Maria Papathanasiou, Vasiliki Lampropoulou, Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Evangelos Eleutherakis-Papaiakovou, Yagnik Vyas, Maria Kotsopoulou, Eirini Katodrytou, Maria Gavriatopoulou, Meletios Dimopoulos
Journal: Blood
Blood (2025) 146 (Supplement 1): 4036.
https://doi.org/10.1182/blood-2025-4036
Published: 2025
Journal Articles

Randomized comparison between isatuximab-rd versus rd induction, followed by isa-R versus R maintenance in very elderly patients with NDMM: Efficacy data on MRD after induction (AGMT-MM04 Trial)

Free
Heinz Ludwig, Thomas Melchardt, Evangelos Terpos, Jelena Bila, Martin Schreder, Sarah Bernhard, Klaus Podar, Eirini Katodrytou, Thamer Sliwa, Predrag Djurdjevic, Sosana Delimpasi, Michael Leisch, Marko Mitrovic, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Eva Maria Autzinger, August Zabernigg, Michael Fillitz, Ewald Wöll, Petra Pichler, Irene Manrique, Bruno Paiva, Richard Greil
Journal: Blood
Blood (2025) 146 (Supplement 1): 2258.
https://doi.org/10.1182/blood-2025-2258
Published: 2025
Journal Articles

Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin and Steroids (PolaRCHP) in Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Real-Life Experience in Greece

Free
Theodoros P. Vassilakopoulos, Maria Panagiota Arapaki, Christina Apostolopoulou, Georgia Kaiafa, Anastasia Mpanti, Chara Giatra, Evgenia Verrou, Maria Anastasia Ioakeim, Evangelia Fedra Triantafyllou, Michael-Evangelos Makris, Athanasios Anastasiadis, Alexia Piperidou, Athanasios Liaskas, Maria Delatola, Aikaterini Koutsi, Vasileios Xanthopoulos, Sotirios Sachanas, Eirini Katodrytou, Maria Bouzani, Marina Siakantaris, Panayiotis Panayiotidis, Maria Angelopoulou, Sotirios G. Papageorgiou
Journal: Blood
Blood (2024) 144 (Supplement 1): 7767.
https://doi.org/10.1182/blood-2024-211525
Published: 2024
Journal Articles

Real-World Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with Teclistamab and Talquetamab; A Multicenter Analysis from the Greek Myeloma Study Group

Free
Ioannis Ntanasis-Stathopoulos, Eirini Katodrytou, Evdoxia Hatjiharissi, Emmanouil Spanoudakis, Vasiliki Douka, Despina Fotiou, Vasiliki Labropoulou, Dimitra Dalampira, Vasiliki Spiliopoulou, Theodosia Papadopoulou, Dimitrios Christoulas, Panagiotis Malandrakis, Anthi Bouchla, Vasiliki Pappa, Efstathios Kastritis, Evangelos Terpos, Meletios Dimopoulos, Maria Gavriatopoulou
Journal: Blood
Blood (2024) 144 (Supplement 1): 6988.
https://doi.org/10.1182/blood-2024-206900
Published: 2024
Journal Articles

Isatuximab in Combination with Pomalidomide and Dexamethasone in RRMM Patients with One Prior Line of Lenalidomide-Containing Therapy: A Phase 2 Study of the Greek Myeloma Study Group

Free
Evangelos Terpos, Maria Gavriatopoulou, Alexandros Spyridonidis, Emmanouil Spanoudakis, Anastasia Sioni, Eirini Katodrytou, Eleftheria Hatzimichael, Maria Kotsopoulou, Nikolaos Giannakoulas, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nasia Antoniou, Nikolaos Kanellias, Anastasia Pouli, Efstathios Kastritis, Meletios Dimopoulos
Journal: Blood
Blood (2024) 144 (Supplement 1): 1991.
https://doi.org/10.1182/blood-2024-203519
Published: 2024
Journal Articles

Isatuximab in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone, Followed By Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients with Multiple Myeloma and Severe Renal Impairment: A Phase 2 Study of the Greek Myeloma Study Group

Free
Evangelos Terpos, Efstathios Kastritis, Sosana Delimpasi, Maria Kotsopoulou, Konstantina Papathanasiou, Vasiliki Labropoulou, Eirini Katodrytou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Giorgos Psarros, Maria Gavriatopoulou, Meletios Dimopoulos
Journal: Blood
Blood (2024) 144 (Supplement 1): 3361.
https://doi.org/10.1182/blood-2024-204707
Published: 2024